NCT07185282 - A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis | Biotech Hunter

Enrollment

375

Participants

Timeline

Start Date

June 10, 2023

Primary Completion Date

December 13, 2024

Study Completion Date

August 15, 2025

Conditions

Atopic Dermatitis (AD)

Interventions

DRUG

MH004 Ointment

MH004 1% ointment applied topically to the affected area as a thin film twice daily.

DRUG

Vehicle Ointment

Matching vehicle ointment applied topically to the affected area as a thin film twice daily.

Trial Locations (1)

Peking University People's Hospital, Beijing